PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17683840-2	2007	We investigated the efficacy of valproic acid (VPA) for reversing a depressive-like behaviour and a cytoskeletal alteration in the hippocampus, the loss of the light neurofilament subunit (NF-L).	Valproic Acid	32-45	neurofilament light chain	Homo sapiens	166-193	
17683840-2	2007	We investigated the efficacy of valproic acid (VPA) for reversing a depressive-like behaviour and a cytoskeletal alteration in the hippocampus, the loss of the light neurofilament subunit (NF-L).	Valproic Acid	47-50	neurofilament light chain	Homo sapiens	166-193	
29876485-2	2018	Following treatment of the HDAC inhibitors, such as MS-275, NaB, TSA, or VPA, the phenotypes of NI-hADSCs exhibit neuron-like features and the neurofilament-L (NFL)-positive cells were increased.	Valproic Acid	73-76	neurofilament light chain	Homo sapiens	143-158	
29876485-2	2018	Following treatment of the HDAC inhibitors, such as MS-275, NaB, TSA, or VPA, the phenotypes of NI-hADSCs exhibit neuron-like features and the neurofilament-L (NFL)-positive cells were increased.	Valproic Acid	73-76	neurofilament light chain	Homo sapiens	160-163